pagibaximab

pagibaximab Suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Pagibaximab
CAS:595566-61-3
Purity:95% Package:100ug;500ug;1mg
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Pagibaximab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Products Intro: Product Name:Research Grade Pagibaximab (DGX03201)
CAS:595566-61-3
Purity:PAGE:>95% Package:100ug;1mg
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Products Intro: Product Name:Pagibaximab
CAS:595566-61-3
Purity:95% Package:100ug:500ug:1mg
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Products Intro: Product Name:Pagibaximab
CAS:595566-61-3
Purity:95.00% Package:1mg;5mg
pagibaximab Basic information
Product Name:pagibaximab
Synonyms:pagibaximab;A 110;BSYX-A 110;Research Grade Pagibaximab (DGX03201);Research Grade Pagibaximab
CAS:595566-61-3
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
pagibaximab Structure
pagibaximab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
pagibaximab Usage And Synthesis
UsesPagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1].
References[1] Weisman LE, et, al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128(2):271-9. DOI:10.1542/peds.2010-3081
pagibaximab Preparation Products And Raw materials
Tag:pagibaximab(595566-61-3) Related Product Information
Alemtuzumab Brodalumab belimumab Lumretuzumab Landogrozumab Sirukumab Rosopatamab Rolinsatamab Avelumab Oleclumab